# Safehold Inc.: financial statements, quarterly

SAFE · NYSE · CIK 1095651 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/safe.md) · [Financials](/companies/safe/financials.md) · [Filings](/companies/safe/filings.md) · [Insiders](/companies/safe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/safe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [85.6](/filings/0001095651-24-000028.md) | [103 d](/filings/0001095651-26-000010.md) | [93.2](/filings/0001095651-25-000016.md) | [89.9](/filings/0001095651-25-000025.md) | [90.7](/filings/0001095651-25-000030.md) | [91.9 d](/filings/0001095651-26-000010.md) | [97.7](/filings/0001095651-26-000017.md) | [93.8](/filings/0001095651-26-000025.md) | [96.2](/filings/0001095651-25-000030.md) | [97.9 d](/filings/0001095651-26-000010.md) | [111](/filings/0001095651-26-000017.md) | [115](/filings/0001095651-26-000025.md) |
| Cost of revenue | $m | [1.0](/filings/0001095651-24-000028.md) | [1.4 d](/filings/0001095651-26-000010.md) | [1.1](/filings/0001095651-25-000016.md) | [1.0](/filings/0001095651-25-000025.md) | [1.0](/filings/0001095651-25-000030.md) | [1.1 d](/filings/0001095651-26-000010.md) | [1.2](/filings/0001095651-26-000017.md) | [0.9](/filings/0001095651-26-000025.md) | [1.4](/filings/0001095651-25-000030.md) | [1.3 d](/filings/0001095651-26-000010.md) | [1.3](/filings/0001095651-26-000017.md) | [0.8](/filings/0001095651-26-000025.md) |
| Operating income | $m | [(130)](/filings/0001095651-24-000028.md) | [34.9 d](/filings/0001095651-26-000010.md) | [24.6](/filings/0001095651-25-000016.md) | [24.0](/filings/0001095651-25-000025.md) | [15.9](/filings/0001095651-25-000030.md) | [22.6 d](/filings/0001095651-26-000010.md) | [25.3](/filings/0001095651-26-000017.md) | [23.9](/filings/0001095651-26-000025.md) | [24.9](/filings/0001095651-25-000030.md) | [26.8 d](/filings/0001095651-26-000010.md) | [25.5](/filings/0001095651-26-000017.md) | [28.3](/filings/0001095651-26-000025.md) |
| Interest expense | $m | [46.6](/filings/0001095651-24-000028.md) | [47.5 d](/filings/0001095651-24-000009.md) | [48.6](/filings/0001095651-24-000016.md) | [49.1](/filings/0001095651-24-000022.md) | [50.0](/filings/0001095651-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001095651-24-000028.md) | [1.1 d](/filings/0001095651-26-000010.md) | [0.5](/filings/0001095651-25-000016.md) | [0.9](/filings/0001095651-25-000025.md) | [0.7](/filings/0001095651-25-000030.md) | [1.4 d](/filings/0001095651-26-000010.md) | [0.9](/filings/0001095651-26-000017.md) | [0.9](/filings/0001095651-26-000025.md) | [0.2](/filings/0001095651-25-000030.md) | [1.0 d](/filings/0001095651-26-000010.md) | [0.7](/filings/0001095651-26-000017.md) | [1.4](/filings/0001095651-26-000025.md) |
| Net income | $m | [(123)](/filings/0001095651-24-000028.md) | [41.2 d](/filings/0001095651-26-000010.md) | [30.7](/filings/0001095651-25-000016.md) | [29.7](/filings/0001095651-25-000025.md) | [19.3](/filings/0001095651-25-000030.md) | [26.0 d](/filings/0001095651-26-000010.md) | [29.4](/filings/0001095651-26-000017.md) | [27.9](/filings/0001095651-26-000025.md) | [29.3](/filings/0001095651-25-000030.md) | [27.9 d](/filings/0001095651-26-000010.md) | [28.9](/filings/0001095651-26-000017.md) | [30.2](/filings/0001095651-26-000025.md) |
| Diluted EPS | $ per share | [(1.81)](/filings/0001095651-24-000028.md) | not reported | [0.43](/filings/0001095651-25-000016.md) | [0.42](/filings/0001095651-25-000025.md) | [0.27](/filings/0001095651-25-000030.md) | not reported | [0.41](/filings/0001095651-26-000017.md) | [0.39](/filings/0001095651-26-000025.md) | [0.41](/filings/0001095651-25-000030.md) | not reported | [0.40](/filings/0001095651-26-000017.md) | [0.42](/filings/0001095651-26-000025.md) |
| Basic EPS | $ per share | [(1.81)](/filings/0001095651-24-000028.md) | not reported | [0.43](/filings/0001095651-25-000016.md) | [0.42](/filings/0001095651-25-000025.md) | [0.27](/filings/0001095651-25-000030.md) | not reported | [0.41](/filings/0001095651-26-000017.md) | [0.39](/filings/0001095651-26-000025.md) | [0.41](/filings/0001095651-25-000030.md) | not reported | [0.40](/filings/0001095651-26-000017.md) | [0.42](/filings/0001095651-26-000025.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.5](/filings/0001095651-24-000028.md) | [18.8](/filings/0001095651-26-000010.md) | [11.3](/filings/0001095651-25-000016.md) | [13.4](/filings/0001095651-25-000025.md) | [15.6](/filings/0001095651-25-000030.md) | [8.3](/filings/0001095651-26-000010.md) | [17.3](/filings/0001095651-26-000017.md) | [13.9](/filings/0001095651-26-000025.md) | [12.1](/filings/0001095651-25-000030.md) | [21.7](/filings/0001095651-26-000025.md) | [19.3](/filings/0001095651-26-000017.md) | [15.9](/filings/0001095651-26-000025.md) |
| Total assets | $m | [6,443](/filings/0001095651-23-000012.md) | [6,548](/filings/0001095651-25-000006.md) | [6,674](/filings/0001095651-24-000016.md) | [6,769](/filings/0001095651-24-000022.md) | [6,815](/filings/0001095651-24-000028.md) | [6,899](/filings/0001095651-26-000010.md) | [6,929](/filings/0001095651-25-000016.md) | [7,063](/filings/0001095651-25-000025.md) | [7,148](/filings/0001095651-25-000030.md) | [7,249](/filings/0001095651-26-000025.md) | [7,382](/filings/0001095651-26-000017.md) | [7,520](/filings/0001095651-26-000025.md) |
| Total liabilities | $m | [4,125](/filings/0001095651-23-000012.md) | [4,253](/filings/0001095651-25-000006.md) | [4,325](/filings/0001095651-24-000016.md) | [4,387](/filings/0001095651-24-000022.md) | [4,497](/filings/0001095651-24-000028.md) | [4,525](/filings/0001095651-26-000010.md) | [4,548](/filings/0001095651-25-000016.md) | [4,659](/filings/0001095651-25-000025.md) | [4,727](/filings/0001095651-25-000030.md) | [4,809](/filings/0001095651-26-000025.md) | [4,920](/filings/0001095651-26-000017.md) | [4,887](/filings/0001095651-26-000025.md) |
| Long-term debt | $m | [3,938](/filings/0001095651-23-000012.md) | [4,054](/filings/0001095651-25-000006.md) | [4,143](/filings/0001095651-24-000016.md) | [4,191](/filings/0001095651-24-000022.md) | [4,296](/filings/0001095651-24-000028.md) | [4,317](/filings/0001095651-26-000010.md) | [4,341](/filings/0001095651-25-000016.md) | [4,444](/filings/0001095651-25-000025.md) | [4,514](/filings/0001095651-25-000030.md) | [4,586](/filings/0001095651-26-000025.md) | [4,697](/filings/0001095651-26-000017.md) | [4,654](/filings/0001095651-26-000025.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,264](/filings/0001095651-23-000012.md) | [2,231](/filings/0001095651-25-000006.md) | [2,283](/filings/0001095651-24-000016.md) | [2,313](/filings/0001095651-24-000022.md) | [2,288](/filings/0001095651-24-000028.md) | [2,344](/filings/0001095651-26-000010.md) | [2,351](/filings/0001095651-25-000016.md) | [2,373](/filings/0001095651-25-000025.md) | [2,390](/filings/0001095651-25-000030.md) | [2,408](/filings/0001095651-26-000025.md) | [2,428](/filings/0001095651-26-000017.md) | [2,439](/filings/0001095651-26-000025.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.8 d](/filings/0001095651-24-000028.md) | [23.1 d](/filings/0001095651-26-000010.md) | [(3.1)](/filings/0001095651-25-000016.md) | [24.8 d](/filings/0001095651-25-000025.md) | [8.3 d](/filings/0001095651-25-000030.md) | [7.9 d](/filings/0001095651-26-000010.md) | [8.9](/filings/0001095651-26-000017.md) | [28.0 d](/filings/0001095651-26-000025.md) | [(1.4) d](/filings/0001095651-25-000030.md) | [12.3 d](/filings/0001095651-26-000010.md) | [(8.6)](/filings/0001095651-26-000017.md) | [34.6 d](/filings/0001095651-26-000025.md) |
| Dividends paid | $m | [11.3 d](/filings/0001095651-24-000028.md) | [12.6 d](/filings/0001095651-26-000010.md) | [12.6](/filings/0001095651-25-000016.md) | [12.7 d](/filings/0001095651-25-000025.md) | [12.6 d](/filings/0001095651-25-000030.md) | [12.6 d](/filings/0001095651-26-000010.md) | [12.7](/filings/0001095651-26-000017.md) | [12.9 d](/filings/0001095651-26-000025.md) | [12.7 d](/filings/0001095651-25-000030.md) | [12.7 d](/filings/0001095651-26-000010.md) | [12.7](/filings/0001095651-26-000017.md) | [13.1 d](/filings/0001095651-26-000025.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [3.2](/filings/0001095651-26-000017.md) | [12.9 d](/filings/0001095651-26-000025.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [86.7](/filings/0001558370-23-001675.md) | [63.7](/filings/0001095651-24-000016.md) | [63.9](/filings/0001095651-24-000022.md) | [68.0](/filings/0001095651-24-000028.md) | [71.2](/filings/0001095651-25-000016.md) | [71.5](/filings/0001095651-25-000025.md) | [71.5](/filings/0001095651-25-000030.md) | [71.6](/filings/0001095651-26-000017.md) | [71.8](/filings/0001095651-26-000025.md) | [71.8](/filings/0001095651-25-000030.md) | [72.0](/filings/0001095651-26-000017.md) | [71.6](/filings/0001095651-26-000025.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 70,816,280 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0001095651-26-000025.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.